Educational article

Clostridioides difficile and toxins

C. difficile is an anaerobic spore-forming bacterium. Antibiotic-associated microbiota changes can facilitate disease in some settings. A toxigenic strain and symptomatic infection are distinct: detecting an organism or…

Overview

C. difficile is an anaerobic spore-forming bacterium. Antibiotic-associated microbiota changes can facilitate disease in some settings. A toxigenic strain and symptomatic infection are distinct: detecting an organism or gene alone does not establish disease.

Biology and practical meaning

GDH, free-toxin and nucleic-acid assays detect different objects. GDH is glutamate dehydrogenase; a positive result does not necessarily indicate toxin. Testing follows clinical indications and specimen requirements. Spores matter for environmental processing; routine disinfection is not always sufficient.

What the assays detect
AssayMeaning
GDHGlutamate dehydrogenase antigen; not proof of free toxin.
ToxinToxin in the sample; sensitivity depends on the method.
NAAT / PCRGenetic target; not automatic proof of disease.

From detection to clinical significance

The same species can be present as colonization and cause disease in another setting. Significance depends on the sampling site, specimen quality, symptoms and other investigations. Screening for carriage and diagnosing disease address different questions.

The laboratory method determines what a result means. Culture detects viable organisms able to grow under the conditions used; a molecular assay detects its specified sequence. DNA detection does not always establish active infection, and a negative culture does not exclude every infectious cause.

Interpretation requires the species name, specimen, date, method and limitations. Repeated detection in clinically significant material may strengthen a hypothesis, but contamination still needs assessment. An antibiogram describes a particular isolate. Regional resistance prevalence provides context and cannot replace that isolate’s result. Finding the same species in several patients prompts investigation; epidemiological linkage requires additional evidence about time, place, exposure and, where appropriate, typing.

Sources

Read next

Educational material from AMR Atlas. Does not replace clinical guidance or laboratory procedures.

Open interactive reader